Rep. Katie Porter wrote a letter on July 6, 2021 to the HHS

New Post Public Reply Private Reply Replies (0) Message Board
Enjay
799
Rep. Katie Porter wrote a letter on July 6, 2021 to the HHS Office of the Inspector General concerning pharma's influence over individuals in the Dept. of Health and Human Services. Citing the example of Aduhelm, she requested "that you immediately investigate the role that pharmaceutical industry executives, consultants, and lobbyists have in the approval of products by the Department of Health and Human Services, and specifically, in the Food and Drug Administration (FDA)." You can read the 4-page letter here. I have not been able to find it anywhere other than on Twitter.

https://twitter.com/RepKatiePorter/status/141...14/photo/1

The Inspector General's office announced this:

https://oig.hhs.gov/reports-and-publications/...000608.asp

Review of the FDA's Accelerated Approval Pathway

The FDA recently approved Aduhelm (aducanumab) to treat patients with Alzheimer's disease using the accelerated approval pathway. The accelerated approval pathway allows the FDA to approve drugs that treat serious conditions and that fill an unmet medical need based on a surrogate endpoint, which is a marker that is thought to predict a clinical benefit. The FDA's approval of Aduhelm raised concerns due to alleged scientific disputes within the FDA, the advisory committee's vote against approval, allegations of an inappropriately close relationship between the FDA and the industry, and the FDA's use of the accelerated approval pathway. In response to these concerns, we will assess how the FDA implements the accelerated approval pathway. This will include reviewing interactions between the FDA and outside parties as well as other aspects of the process, such as deciding on this pathway and scientific disputes. We will review the FDA's relevant policies and procedures, determine compliance with them, and make appropriate findings and recommendations based on a sample of drugs approved using the accelerated approval pathway, which will include Aduhelm. We will not assess the scientific appropriateness of the FDA's approval of any of the drugs under review. This work may result in multiple reports.

I hope that the investigation leads to a deep dive into the influence big pharma has at the FDA in all aspects of approval, not just the accelerated approval pathway.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 74

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 66

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 107

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 407

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 181

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 481

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 473

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 689

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 744

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Trends in the Office Sleep Pod Market: A Growth Story

Updated Category News Views 187

Overview of the Office Sleep Pod Market The Office Sleep Pod Market is witnessing a remarkable surge, driven by a confluence of factors centered around workplace wellness, the link between rest and employee productivity, and the incorporation of modern workplace infrastructure by global companies. The appetite for sleep pods is being fueled by stress-laden corporate...

Continue Reading
Ancient Crunch Expands into Whole Foods' 400 Stores

Updated Category News Views 28

The Move into Whole Foods: A Strategic Leap If you'd told me years ago that a snack made with beef tallow would make waves in the premium grocery market, I'd have laughed in your face. But here we are—Ancient Crunch is making a bold power play into Whole Foods Market, placing their sons of grit and gusto, MASA and Vandy, onto 400 new shelves nationwide. It's like...

Continue Reading
Acuity Brands Unveils Comprehensive Environmental Report 2024

Updated Category News Views 294

Acuity Brands Reveals its EarthLIGHT Report for 2024 ATLANTA, Dec. 10, 2024 - Acuity Brands, Inc. (NYSE: AYI), a leading industrial technology company, has published its annual EarthLIGHT Report. This document outlines significant accomplishments in Environmental, Social, and Governance (ESG) for the fiscal year 2024, while also providing insights into key strategic...

Continue Reading
RAPT Therapeutics Announces Participation in Investor Conferences

Updated Category News Views 138

RAPT Therapeutics to Engage Investors in Upcoming Conferences RAPT Therapeutics, Inc. (NASDAQ: RAPT), an innovative biopharmaceutical company based in South San Francisco, is gearing up for a series of influential investor conferences this March. The company's focus on developing cutting-edge therapies for immunological conditions positions them at the forefront of...

Continue Reading
Opus One Gold Completes Final Tranche of Private Placement Funding

Updated Category News Views 66

Opus One Gold Completes Final Tranche of Private Placement Funding Opus One Gold Corporation (OOR: TSXV) has achieved a significant milestone by wrapping up the second tranche of its private placement. This non-brokered offering has successfully drawn in substantial investment, reflecting strong market confidence in Opus One’s potential. Details of the Offering In this...

Continue Reading